Error message
Notice: Undefined index: content in _drupal_default_html_head() (line 345 of /var/www/vhosts/rovi.es/httpdocs/includes/common.inc).
|
Date |
Title |
Description |
PDF |
|
24 Jul 2025 |
On P&L |
The Company releases the press release related to the first half of 2025 financial results
|
Download |
|
24 Jul 2025 |
On P&L |
The Company releases the first half 2025 financial results presentation
|
Download |
|
25 Mar 2025 |
On business and financial situation |
The Company releases the presentation related to its strategy update because of its 2025 Capital Markets Day
|
Download |
|
25 Feb 2025 |
About Corporate Governance |
The Company informs about the agreements adopted by the Board of Directors
|
Download |
|
25 Feb 2025 |
On P&L |
The Company releases the press release related to the full year 2024 financial results
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
06 May 2026 |
Announcement of general shareholders’ meeting |
The Company announces the calling of its 2026 Ordinary General Shareholder´s Meeting.
|
Download |
|
01 Apr 2026 |
On corporate transactions |
ROVI announces the closing of the Asset Purchase Agreement entered into in September 2025 for the acquisition of a pharmaceutical manufacturing facility in Phoenix, Arizona (USA)
|
Download |
|
25 Feb 2026 |
Annual Corporate Governance Report |
The Company submits the Annual Corporate Governance Report for fiscal year 2025.
|
Download |
|
25 Feb 2026 |
Annual Report regarding remuneration of the members of the Board of Directors |
ROVI releases the 2025 annual report regarding remuneration of the members of the Board of Directors.
|
Download |
|
18 Nov 2025 |
On business and financial situation |
The Company releases the press release in relation to the signing of the definitive collaboration agreement with Roche for the manufacture of a new medicine in development
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
08 Jan 2018 |
Contratos de liquidez y contrapartida |
Liquidity contract: transactions conducted in the fourth quarter of 2017
|
Download |
|
21 Dec 2017 |
Préstamos, créditos y avales |
ROVI and the EIB agree to sign a loan to boost research into drug administration and prolonged-release technologies
|
Download |
|
08 Nov 2017 |
Información sobre Resultados |
ROVI releases the press release related to the nine-month period ended 30 September 2017 results
|
Download |
|
08 Nov 2017 |
Información sobre Resultados |
ROVI releases the presentation related to the nine-month period ended 30 September 2017 results.
|
Download |
|
24 Oct 2017 |
Otros sobre negocio y situación financiera |
The Company releases the presentation related to the update of its Phase III-Prima 3 Risperidone ISM® project.
|
Download |
Pages
